{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["N/A"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001010300"],"sample_count":["1"],"description":["EGA dataset EGAD00001010300"],"repository":["EGA"],"title":["Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer using Cell-Free DNA Fragmentomics"],"additional_accession":[]},"is_claimable":false,"name":"5796737e-4882-4a48-afe6-b2d7f2dd829b - samples","description":"The circulating tumor DNA (ctDNA) mutation-based approach shows limited performance in minimal residual disease (MRD) detection, especially for landmark MRD detection at an early-stage cancer after surgery. Here, A total of 87 NSCLC patients, who received curative surgical resections (23 patients relapsed during follow-up), enrolled in this study. A total of 163 plasma samples, collected at 7 days and 6 months postsurgical, were used for high-throughput sequencing.","dates":{"updated":"2023-05-05 13:04:10"},"accession":"EGAD00001010300","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAC00001003206","EGAS00001007192"]}}